Published in Gut on September 01, 2001
Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage | NCT02903017
Topical tranexamic acid as a novel treatment for bleeding peptic ulcer: A randomised controlled trial. Afr J Paediatr Surg (2016) 0.75
Upper gastrointestinal bleeding and surrogate end points. Gut (2002) 0.75
Endoscopy in gastrointestinal bleeding. Lancet (1974) 4.02
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17
Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med (2000) 3.12
Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology (1992) 3.06
Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. N Engl J Med (1983) 2.72
Stigmata of recent haemorrhage in diagnosis and prognosis of upper gastrointestinal bleeding. Br Med J (1978) 2.17
A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med (1997) 2.04
Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med (1985) 2.04
Variation in outcome after acute upper gastrointestinal haemorrhage. The National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet (1995) 2.03
Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol (1997) 2.02
Endoscopic injection of adrenaline for actively bleeding ulcers: a randomised trial. Br Med J (Clin Res Ed) (1988) 1.97
Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. BMJ (1989) 1.85
Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol (1997) 1.44
Do the stigmata of recent haemorrhage have additional prognostic value in patients with bleeding duodenal ulcer? Scand J Gastroenterol Suppl (1988) 1.06
Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet (1992) 0.90
Rolling review: upper gastrointestinal bleeding. Aliment Pharmacol Ther (1993) 0.85
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med (1998) 3.96
A randomised prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding after acute dysphagic stroke. BMJ (1996) 3.83
Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology. Gut (2000) 3.22
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17
Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology (1985) 3.12
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med (1996) 2.37
A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology (1976) 2.25
Prospective survey of investigations in outpatients referred with iron deficiency anaemia. Gut (1993) 2.21
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet (1993) 2.20
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A (1997) 2.12
Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy. Lancet (1993) 2.10
The endoscopic appearance of duodenal folds is predictive of untreated adult celiac disease. Gastrointest Endosc (1992) 2.01
Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection. BMJ (1994) 1.99
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Prescribing in the UK. Lancet (2001) 1.93
Journals should see original protocols for clinical trials. BMJ (2001) 1.88
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders. Drugs (1998) 1.74
Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol (1997) 1.70
Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol (1999) 1.69
Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology (1977) 1.65
Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology (1997) 1.59
High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut (1991) 1.58
Effect of neurotensin on gastric function in man. Lancet (1980) 1.55
Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci (Lond) (1992) 1.53
Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther (2010) 1.48
Dissecting intramural haematoma of the oesophagus. Eur J Gastroenterol Hepatol (2000) 1.45
Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy (2010) 1.44
Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3. Am J Physiol (1999) 1.42
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
Adenomatous colonic polyps are rare in ulcerative colitis. Aliment Pharmacol Ther (2004) 1.41
Ileo-caecal ulceration associated with the use of diclofenac slow release. Aliment Pharmacol Ther (1993) 1.40
Experience of 5-aminosalicylate nephrotoxicity in the United Kingdom. Aliment Pharmacol Ther (2005) 1.40
Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary report. Nucl Med Commun (1992) 1.39
Somatostatin in treatment of haematemesis and melaena. Lancet (1985) 1.39
Omission after admission: failure in prescribed medications being given to inpatients. Clin Med (2009) 1.38
A perspective on iron deficiency anaemia. Gut (1993) 1.38
The Prader-Willi syndrome with a 15/15 translocation. Case report and review of the literature. J Med Genet (1976) 1.38
Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa. Gut (1983) 1.37
Prostaglandins and ulcerative colitis. Gut (1984) 1.36
Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther (2002) 1.35
The practice of rectal examination. Postgrad Med J (1991) 1.34
An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol (2003) 1.34
Inhibition of prostaglandin synthetase in human rectal mucosa. Gut (1983) 1.32
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther (2005) 1.32
Intravenous omeprazole rapidly raises intragastric pH. Gut (1985) 1.31
High definition colonoscopy vs. standard video endoscopy for the detection of colonic polyps: a meta-analysis. Endoscopy (2011) 1.30
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut (1992) 1.30
Allelic diversity of the Helicobacter pylori vacuolating cytotoxin gene in South Africa: rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele. J Clin Microbiol (1999) 1.28
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther (2005) 1.27
Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer. Gut (1986) 1.27
Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease. Lancet (1976) 1.27
Role of percutaneous transhepatic obliteration of varices in the management of hemorrhage from gastroesophageal varices. Gastroenterology (1981) 1.26
Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci (1994) 1.26
Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging. Aliment Pharmacol Ther (2007) 1.25
Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology. Endoscopy (2008) 1.24
Vacuolating cytotoxin (vacA) alleles of Helicobacter pylori comprise two geographically widespread types, m1 and m2, and have evolved through limited recombination. Curr Microbiol (1999) 1.23
Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease. Gut (1983) 1.21
Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol (1997) 1.21
Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut (1998) 1.20
Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut (1978) 1.19
Percutaneous transhepatic obliteration of gastro-oesophageal varices. Lancet (1976) 1.19
Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. BMJ (1989) 1.18
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford) (1999) 1.16
Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol (1990) 1.16
Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci (1985) 1.16
The impact of the two-week wait scheme for suspected gastrointestinal cancers. Clin Med (2003) 1.15
Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut (2000) 1.15
A national training programme for gastroenterology and hepatology. Gut (1996) 1.14
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther (2001) 1.13
Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach. Clin Sci (Lond) (1991) 1.13
Somatostatin and the dumping syndrome. Br Med J (Clin Res Ed) (1985) 1.10
Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs. Gut (1995) 1.09
Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2006) 1.09
25-Hydroxylation of vitamin D in primary biliary cirrhosis. Lancet (1977) 1.09
Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol (1991) 1.08
Misoprostol, smoking, and duodenal ulcer healing rates. Lancet (1987) 1.08
Cost-effectiveness of thiopurine methyltransferase genotype screening in IBD. Aliment Pharmacol Ther (2005) 1.08
Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther (1998) 1.07
Proposed pathogenic mechanism for the diarrhea associated with human intestinal spirochetes. Am J Clin Pathol (1986) 1.07
Further advice on insertion of Hickman-type catheters. Br J Hosp Med (1992) 1.06
Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut (1997) 1.05
Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet (1977) 1.04
Effect of information leaflets on knowledge in patients with gastrointestinal diseases. Gut (1989) 1.04
Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut (1993) 1.04
Colitis associated with non-steroidal anti-inflammatory drugs. Br Med J (Clin Res Ed) (1984) 1.03
Gastric mucosal protection with selective inhibition of thromboxane synthesis. Gut (1987) 1.03
Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus. Aliment Pharmacol Ther (2006) 1.03
Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut (1993) 1.03
Contrasting liver function test patterns in obstructive jaundice due to biliary strictures [corrected] and stones. QJM (2005) 1.02
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer. Gut (2003) 1.01